GCO Stock Analysis: Genesco | NYSE
Apparel Retail | NYSE, USA | Market Cap: 368m USD | 12M Return: 41.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.20M
EPS Trend: 11.6%
Qual. Beats: 1
Rev. Trend: 81.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Genesco Inc. (NYSE: GCO) is a Nashville, Tennessee-based footwear retailer and wholesaler founded in 1934 and publicly traded since 1985. The company operates through four segments: Journeys Group (youth-focused footwear retail in North America), Schuh Group (footwear retail in the UK and Ireland), Johnston & Murphy Group (mens footwear retail, e-commerce, and wholesale), and Genesco Brands Group (wholesale licensing of branded footwear, including Levis and Dockers). Genesco sells through retail stores, catalogs, and multiple e-commerce websites across the United States, Puerto Rico, Canada, the United Kingdom, and Ireland.
As a small-cap stock in the Apparel Retail sub-industry of Consumer Discretionary, Genescos results are closely tied to discretionary consumer spending and fashion trends. Its business combines company-owned retail banners with a wholesale/licensing model that markets footwear under third-party brands, providing diversified revenue streams across both owned retail and brand-licensing wholesale channels.
- Journeys teen segment sales lift holiday quarter comparable results
- UK Schuh retailer margins squeezed by consumer spending slowdown
- Footwear import tariffs compress gross margins across all segments
| Net Income: 19.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 13.01 > 1.0 |
| NWC/Revenue: 11.06% < 20% (prev 12.91%; Δ -1.85% < -1%) |
| CFO/TA 0.10 > 3% & CFO 144.0m > Net Income 19.7m |
| Net Debt (1.08b) to EBITDA (83.3m): 12.96 < 3 |
| Current Ratio: 1.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (10.4m) vs 12m ago -0.64% < -2% |
| Gross Margin: 46.33% > 18% (prev 47.05%; Δ -0.73% > 0.5%) |
| Asset Turnover: 175.7% > 50% (prev 166.7%; Δ 8.95% > 0%) |
| Interest Coverage Ratio: 8.08 > 6 (EBIT TTM 30.1m / Interest Expense TTM 3.72m) |
| A: 0.20 (Total Current Assets 595.8m - Total Current Liabilities 324.9m) / Total Assets 1.38b |
| B: 0.18 (Retained Earnings 248.9m / Total Assets 1.38b) |
| C: 0.02 (EBIT TTM 30.1m / Avg Total Assets 1.39b) |
| D: 0.66 (Book Value of Equity 552.4m / Total Liabilities 831.6m) |
| Altman-Z'' = 2.71 = A |
| DSRI: 0.86 (Receivables 47.7m/52.8m, Revenue 2.45b/2.34b) |
| GMI: 1.02 (GM 47.05% / 46.33%) |
| AQI: 1.02 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 1.05 (Revenue 2.45b / 2.34b) |
| TATA: -0.09 (NI 19.7m - CFO 144.0m) / TA 1.38b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of July 12, 2026, the stock is trading at USD 34.12 with a total of 72,749 shares traded. Over the past week, the price has changed by +2.90%, over one month by -12.56%, over three months by +7.40% and over the past year by +41.58%.
Current recommended Stop Loss: 30.30 (which is 11.2% or 2.1 ATR below the current price).
Genesco has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold GCO.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 40.3 | 18.2% |
P/E Trailing = 17.9243
P/E Forward = 18.4502
P/S = 0.1504
P/B = 0.6826
P/EG = 0.6838
Revenue TTM = 2.45b USD
EBIT TTM = 30.1m USD
EBITDA TTM = 83.3m USD
Long Term Debt = 45.3m USD (from longTermDebt, last quarter)
Short Term Debt = 115.8m USD (from shortTermDebt, last quarter)
Debt = 1.11b USD (from shortLongTermDebtTotal, last quarter) + Leases 530.4m
Net Debt = 1.08b USD (calculated: Debt 1.11b - CCE 27.1m)
Enterprise Value = 1.45b USD (368.3m + Debt 1.11b - CCE 27.1m)
Interest Coverage Ratio = 8.08 (Ebit TTM 30.1m / Interest Expense TTM 3.72m)
EV/FCF = 9.81x (Enterprise Value 1.45b / FCF TTM 147.5m)
FCF Yield = 10.19% (FCF TTM 147.5m / Enterprise Value 1.45b)
FCF Margin = 6.02% (FCF TTM 147.5m / Revenue TTM 2.45b)
Net Margin = 0.80% (Net Income TTM 19.7m / Revenue TTM 2.45b)
Gross Margin = 46.33% ((Revenue TTM 2.45b - Cost of Revenue TTM 1.31b) / Revenue TTM)
Gross Margin QoQ = 47.00% (prev 45.89%)
Tobins Q-Ratio = 1.05 (Enterprise Value 1.45b / Total Assets 1.38b)
Interest Expense / Debt = 0.34% (Interest Expense 3.72m / Debt 1.11b)
Taxrate = 25.38% (6.69m / 26.4m)
NOPAT = 22.5m (EBIT 30.1m * (1 - 25.38%))
Current Ratio = 1.83 (Total Current Assets 595.8m / Total Current Liabilities 324.9m)
Debt / Equity = 2.00 (Debt 1.11b / totalStockholderEquity, last quarter 552.4m)
Debt / EBITDA = 12.96 (Net Debt 1.08b / EBITDA 83.3m)
Debt / FCF = 7.31 (Net Debt 1.08b / FCF TTM 147.5m)
Total Stockholder Equity = 534.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.41% (Net Income 19.7m / Total Assets 1.38b)
RoE = 3.68% (Net Income TTM 19.7m / Total Stockholder Equity 534.9m)
RoCE = 5.19% (EBIT 30.1m / Capital Employed (Equity 534.9m + L.T.Debt 45.3m))
RoIC = 1.96% (NOPAT 22.5m / Invested Capital 1.15b)
WACC = 3.48% (E(368.3m)/V(1.47b) * Re(13.16%) + D(1.11b)/V(1.47b) * Rd(0.34%) * (1-Tc(0.25)))
Discount Rate = 13.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -60.0 | Cagr: -2.44%
[DCF] Terminal Value 75.44% ; FCFF base≈147.5m ; Y1≈148.1m ; Y5≈156.9m
[DCF] Fair Price = 122.6 (EV 2.44b - Net Debt 1.08b = Equity 1.36b / Shares 11.1m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 11.56 | EPS CAGR: 10.12% | SUE: 1.85 | # QB: 1
Revenue Correlation: 81.43 | Revenue CAGR: 1.92% | SUE: 0.69 | # QB: 0
EPS current Quarter (2026-07-31): EPS=-1.37 | Chg30d=-17.13% | Revisions=-29% | Analysts=4
EPS next Quarter (2026-10-31): EPS=1.19 | Chg30d=-5.36% | Revisions=+0% | Analysts=4
EPS current Year (2027-01-31): EPS=2.25 | Chg30d=+5.39% | Revisions=+57% | GrowthEPS=+55.2% | GrowthRev=-0.3%
EPS next Year (2028-01-31): EPS=2.86 | Chg30d=+4.47% | Revisions=+57% | GrowthEPS=+27.2% | GrowthRev=+2.3%
[Analyst] Revisions Ratio: +32% (up=11, down=5)